Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
23.09
+0.57 (2.53%)
Nov 22, 2024, 4:00 PM EST - Market closed
Rapport Therapeutics Market Cap
Rapport Therapeutics has a market cap or net worth of $844.55 million as of November 22, 2024.
Market Cap
844.55M
Enterprise Value
525.54M
1-Year Change
n/a
Ranking
Category
Stock Price
Market Cap Chart
Since the IPO on June 7, 2024, Rapport Therapeutics's market cap has increased from $601.40M to $844.55M, an increase of 40.43%. That is a compound annual growth rate of 111.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 814.92M | 35.50% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Paragon 28 | 873.20M |
| Liquidia | 859.06M |
| Healthcare Services Group | 844.31M |
| Cytek Biosciences | 832.12M |
| Evolus | 825.71M |
| Tyra Biosciences | 812.11M |
| Capricor Therapeutics | 808.91M |
| Castle Biosciences | 808.85M |